We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-0.86%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.19B
AUM Growth
-$288M
Cap. Flow
-$155M
Cap. Flow %
-13.04%
Top 10 Hldgs %
42.35%
Holding
170
New
36
Increased
27
Reduced
26
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$49M
2
LLY icon
Eli Lilly
LLY
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$26.3M
4
PANW icon
Palo Alto Networks
PANW
+$13.1M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$60.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.4M
3
GNRC icon
Generac Holdings
GNRC
+$14.3M
4
LPSN icon
LivePerson
LPSN
+$14.2M
5
AMZN icon
Amazon
AMZN
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 63.14%
2 Technology 10.82%
3 Industrials 3.99%
4 Financials 3.13%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLAC
101
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$1.24M 0.1%
126,687
– –
MGIC
102
DELISTED
Magic Software Enterprises
MGIC
$1.15M 0.1%
57,704
+41,728
+261% +$785K
OMEG
103
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$974K 0.08%
100,000
– –
ACIU icon
104
AC Immune
ACIU
$223M
$812K 0.07%
+121,019
New +$866K
KA
105
DELISTED
Kineta, Inc. Common Stock
KA
$783K 0.07%
10,834
-5,637
-34% -$399K
CMLTU
106
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
$769K 0.06%
75,000
– –
IONS icon
107
Ionis Pharmaceuticals
IONS
$8.6B
$738K 0.06%
+22,000
New +$829K
AMZN icon
108
Amazon
AMZN
$2.92T
$529K 0.04%
3,220
-78,000
-96% -$13.5M
UPWK icon
109
Upwork
UPWK
$1.13B
$450K 0.04%
+10,000
New +$487K
IMTXW
110
DELISTED
Immatics N.V. Warrants
IMTXW
$423K 0.04%
100,000
– –
SRSA
111
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$236K 0.02%
23,900
– –
IMCR icon
112
Immunocore
IMCR
$1.72B
$157K 0.01%
+4,235
New +$143K
LOGC
113
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$110K 0.01%
+24,042
New +$106K
OTLKW
114
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$26K ﹤0.01%
129,500
– –
AGIO icon
115
CALL
Agios Pharmaceuticals
AGIO
$1.79B
– –
-116,000
Closed -$6.39M
ALDX icon
116
Aldeyra Therapeutics
ALDX
$92.9M
– –
-150,000
Closed -$1.7M
ARKO icon
117
ARKO Corp
ARKO
$896M
– –
-369,875
Closed -$3.4M
ATER icon
118
CALL
Aterian
ATER
$4.45M
– –
-29,633
Closed -$5.2M
ATER icon
119
Aterian
ATER
$4.45M
– –
-33,333
Closed -$5.85M
BEAM icon
120
Beam Therapeutics
BEAM
$2.63B
– –
-28,425
Closed -$3.66M
BIIB icon
121
Biogen
BIIB
$30B
– –
-23,995
Closed -$7.86M
CELC icon
122
Celcuity
CELC
$4.21B
– –
-45,000
Closed -$1.08M
CRIS icon
123
Curis
CRIS
$9.78M
– –
-1,471
Closed -$4.75M
ELEV
124
DELISTED
Elevation Oncology
ELEV
– –
-30,000
Closed -$407K
ENPH icon
125
CALL
Enphase Energy
ENPH
$4.96B
– –
-230,000
Closed -$42.2M
3 4
5
6 7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sphera Funds Management held 170 positions worth $1.19B, down 19% from $1.48B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $155M in Q3 2021, closing 54 positions and reducing 26 holdings. Its most notable exit was Merck, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 55% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Pfizer worth $47.6M.

  • Sphera Funds Management's largest Q3 2021 buy was Pfizer: 1,106,528 shares worth $47.6M.
  • Sphera Funds Management added most to Eli Lilly in Q3 2021, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $28.4M.
  • Sphera Funds Management fully exited Merck in Q3 2021, selling an estimated $60.1M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $1.19B portfolio in Q3 2021.
  • Sphera Funds Management opened 36 new positions and closed 54 in Q3 2021.
  • Sphera Funds Management's portfolio value fell 19% quarter-over-quarter to $1.19B.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.